Assembly Biosciences
ASMB
27 hedge funds and large institutions have $8.97M invested in Assembly Biosciences in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.
183% more call options, than puts
Call options by funds: $82K | Put options by funds: $29K
55% more capital invested
Capital invested by funds: $5.77M → $8.97M (+$3.19M)
4% less funds holding
Funds holding: 28 → 27 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$2.36M |
| 2 |
Millennium Management
New York
|
+$568K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$378K |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$236K |
| 5 |
Jane Street
New York
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$535K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$109K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$97K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$90K |
| 5 |
Renaissance Technologies
New York
|
-$86.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$109K | -1,441 | Closed |
|
|
BFA
27
BlackRock Fund Advisors
San Francisco,
California
| – | -$97K | -1,266 | Closed |
|
|
VKH
28
Virtu KCG Holdings
New York
| – | -$60K | -794 | Closed |
|
|
BRWA
29
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$30K | -393 | Closed |
|
|
U
30
UBS
Zurich,
Switzerland
| – | -$26.3K | -371 | Closed |
|
|
GC
31
Guggenheim Capital
Chicago,
Illinois
| – | -$14K | -176 | Closed |
|
32
Citigroup
New York
| – | -$1.92K | -27 | -87% |
|
ASMB Hedge Fund Activity: Q2 2014 in Review
27 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2014, worth a combined $8.97M — up 55% from $5.77M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ASMB and 6 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 4 added.
The largest buyer was Jennison Associates, opening a new position worth an estimated $2.36M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $535K sold.
- 27 institutional investors held Assembly Biosciences (ASMB) as of Q2 2014, down from 28 in Q1 2014.
- Funds reported $8.97M of Assembly Biosciences stock for Q2 2014, up 55% quarter-over-quarter.
- 6 funds opened new Assembly Biosciences positions in Q2 2014 and 7 closed out, a net change of -1 holder.
- The largest Assembly Biosciences buyer in Q2 2014 was Jennison Associates, an estimated $2.36M added.
- The largest Assembly Biosciences seller in Q2 2014 was Baker Bros. Advisors, an estimated $535K sold.
Based on aggregated 13F filings for Q2 2014.